APEX1 and non-small cell lung carcinoma: For this reason, the aim of the present work was to address in vitro the impact of a novel therapeutic strategy based on targeting APE1 redox function in NSCLC in order to increase the efficacy of platinum-based chemotherapy and reduce its possible resistance.